- About Us
- Nano-Social Network
- Nano Consulting
- My Account
iCAD, Inc. (Nasdaq:iCAD), an industry-leading provider of Computer-Aided Detection (CAD)
solutions for the early identification of cancer, today announced that the
Company's CEO, Ken Ferry, has been invited to participate in the
prestigious Future in Review (FiRe) Conference. The Conference runs from
May 22 to 25, 2007, at the Hotel del Coronado in San Diego, California.
iCAD joins EMC, Symantec and Intel Health Research & Innovation Group,
among other technology leaders at the conference.
Mark Anderson, founder and publisher of the Strategic News Service and
expert source on future technologies, contributes to Fortune, the Wall
Street Journal and the New York Times correctly predicting accurate
forecasts of important technology market shifts. The FiRe conference hosted
by Mark Anderson provides world experts and participants with a view of the
future in technology, including nanotechnology, space travel, biology and
medical diagnostics, policy, and other fields.
"The annual FiRe conference offers participants exposure to new ideas
and thought leaders on the cutting edge of technology," said Mark Anderson,
chairman of FiRe and founder and publisher of the Strategic News Service.
"iCAD was selected to participate in FiRe because the Company's CAD
technology is shaping the future of cancer screening, from mammography to
virtual colonoscopy and beyond. CAD technology is vital to the early
identification of cancer, which studies have shown impacts treatment
options, survival and overall patient outcomes."
"iCAD is honored to be selected as a participant at the 2007 FiRe
conference," said Ken Ferry, Chief Executive Officer of iCAD. "As the only
company 100 percent focused on advancing CAD solutions, iCAD is leading the
development of future systems that enable physicians to detect cancers
earlier. The Company's commitment to digital imaging will continue to
expand as we explore applications in 3D mammography and virtual
About iCAD, Inc.
iCAD, Inc. (Nasdaq: iCAD) is an industry-leading provider of Computer-
Aided Detection (CAD) solutions that enable healthcare professionals to
better serve patients by identifying pathologies and pinpointing cancer
earlier. iCAD offers a comprehensive range of high-performance, upgradeable
CAD systems for the high, mid and low volume mammography markets. iCAD is
entrusted with the task of early cancer detection by over one thousand
women's healthcare centers worldwide. For more information, call
+1-877-iCADnow or visit http://www.icadmed.com .
For more information, please click here
iCAD Public Relations
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanometrics to Present at the 19th Annual Needham Growth Conference December 22nd, 2016